Provided by Tiger Trade Technology Pte. Ltd.

Beam Therapeutics, Inc.

25.60
-1.1600-4.33%
Volume:1.46M
Turnover:38.34M
Market Cap:2.60B
PE:-5.79
High:27.87
Open:26.80
Low:25.53
Close:26.76
52wk High:35.25
52wk Low:13.53
Shares:101.47M
Float Shares:89.94M
Volume Ratio:0.93
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4193
EPS(LYR):-4.5769
ROE:-47.19%
ROA:-23.48%
PB:2.69
PE(LYR):-5.59

Loading ...

Beam Therapeutics Nets $255 Million From Orbital Therapeutics Sale

Reuters
·
Dec 12

Beam Therapeutics Reports Durable Efficacy and Safety for Risto-cel in Sickle Cell Disease Trial

Reuters
·
Dec 06

Beam Therapeutics Reports Updated Data From Beacon Phase 1/2 Trial of Ristoglogene Autogetemcel (Risto-Cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (Scd) at American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS
·
Dec 06

Beam Therapeutics (BEAM) Is Up 6.8% After Analyst Optimism Around Sickle Cell Base-Editing Progress - What's Changed

Simply Wall St.
·
Dec 05

Does Beam Therapeutics' $1.1B Cash Position and Clinical Progress Reinforce the BEAM Investment Case?

Simply Wall St.
·
Nov 19

Cathie Wood Bets Big on This Peter Thiel-Backed Coinbase Rival as Bitcoin Crashes Below $91,000

Benzinga
·
Nov 18

Beam Therapeutics’ BEAM-101: Advancements in Sickle Cell Disease Therapy and Manufacturing Efficiency Drive Buy Rating

TIPRANKS
·
Nov 14

RBC Capital Sticks to Their Hold Rating for Beam Therapeutics (BEAM)

TIPRANKS
·
Nov 06

Beam Therapeutics (BEAM) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Nov 05

CRSP, BEAM, ROKU, SOFI: Cathie Wood Pours $17 Million into Biotech Stocks, Trims Tech Favorites

TIPRANKS
·
Nov 05

Cathie Wood’s ARK Investment buys 291K shares of Beam Therapeutics today

TIPRANKS
·
Nov 05

Beam Therapeutics Q3 net loss wider than expected on higher R&D expenses

Reuters
·
Nov 04

Beam Therapeutics reports third quarter cash position of $1.1 billion

Reuters
·
Nov 04

Beam Therapeutics Q3 License and Collaboration Revenue USD 9.698 Million

THOMSON REUTERS
·
Nov 04

Beam Therapeutics Inc - Q3 EPS $-1.10

THOMSON REUTERS
·
Nov 04

Beam Therapeutics to Present Updated BEAM-101 Sickle Cell Trial Data at ASH 2025

Reuters
·
Nov 03

Fmr Llc Makes a Strategic Move with Beam Therapeutics Stock!

TIPRANKS
·
Oct 30

FMR LLC Reports Disposal of Beam Therapeutics Inc. Common Shares

Reuters
·
Oct 30

Beam Therapeutics’ BEAM-301 Study: A Promising Step in Rare Disease Treatment

TIPRANKS
·
Oct 28

AI Biotech Stocks Shined. Recursion Up 15%; Beam Up 14%; Tempus Up 7%; Novavax Up 6%; Crispr And Ginkgo Up 4%; Hims Up 2%

Tiger Newspress
·
Oct 20